•  
  •  
  •  
  •  

2022-08-11 20:26:53

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Akar Auto Industries Ltd Q1FY23 net profit drops QoQ to Rs. 1.22 crore
  • Chemtech Industrial Valves Ltd Q1FY23 PAT up at Rs. 33.47 lakhs
  • Mohit Paper Mills Ltd posts net profit of Rs. 85.45 lakhs in Q1FY23
  • Mindteck India Ltd reports Rs. 5.12 crores consolidated PAT in Q1FY23
  • KJMC Financial Services Ltd consolidated Q1FY23 loss at Rs. 52.98 lakhs

Keywords Selected:  NMA

Research

  • Quant Thematic - Three factor model for stocks filtration
  • Why Indians should not panic and go long on India?
  • Mr. Dhiraj Relli's Outlook on Performance of India markets in 2021 & Expectations from 2022

Market Commentary

  • Weekly Report - July 9, 2022 - Reliance Securities
  • Technical Wrap on Indian Markets - Jan 11, 2022 - HDFC Securities
  • The Indian market is showing strong strength despite rising COVID cases - Tradingo
  • Indian equity market begin 2022 on a cheerful note - Swastika Investmart Ltd
  • Indian market witnessed a sharp sell-off today - Mr. Santosh Meena, Head of Research, Swastika Investmart

IPO News

  • Noida-based India Exposition Mart gets Sebi nod for IPO
  • India Exposition Mart files DRHP for Rs 600 crore IPO

Stock Report

  • Jain Marmo Industries Ltd Q1 FY2023 loss at Rs. 7.10 lakhs
  • Miven Machine Tools Ltd Q1FY23 loss at Rs. 34.90 lakhs
  • Chemplast Sanmar Ltd consolidated Q1FY23 PAT falls QoQ to Rs. 40.59 crores
  • Glenmark Life Sciences Ltd Q1FY23 PAT up QoQ at Rs. 108.73 crores
  • Southern Magnesium and Chemicals Ltd Q1FY23 PAT zooms to Rs. 1.32 crore
  • Glenmark Pharmaceuticals receives ANDA approval for generic version of Taytulla®
  • Spark Minda Forays into Consumer Space with the launch of Protective Head Gear
  • Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray
  • Techno Electric & Engineering Company Ltd approves buy back through open market route
  • Glenmark Pharmaceuticals launches MINYM® GEL for the treatment of Moderate to Severe Acne
  • Marksans Pharma Ltd board approves buyback
  • Glenmark launches Sitagliptin and its Fixed Dose Combinations
  • PVR Cinemas remodel multiplex at PVR R Odeon Mall in Ghatkopar East
  • USFDA issues Form 483 for Glenmark Pharmaceuticals Ltd's Aurangabad facility
  • Route Mobile approves buyback through open market route
  • Bajaj Auto Ltd approves buyback through open market purchase
  • U.S. FDA inspection at Glenmark Pharmaceuticals Ltd's Baddi, India Facility
  • Glenmark becomes the First Pharmaceutical Company to launch Indacaterol + Mometasone Fixed-Dose Combination Drug for Asthma in India
  • Tata Elxsi wins 'Golden Peacock Innovation Management Award' for 2021
  • Glenmark Pharmaceuticals recommends dividend of Rs. 2.50
  • Glenmark Pharmaceuticals Ltd Q4 FY2022 consolidated PAT lower at Rs. 155.58 crores
  • Glenmark Pharma gets 5 observations from U.S. FDA for its Goa, India Facility
  • Glenmark Pharma gets 17 observations from U.S. FDA for its Monroe, North Carolina (USA) Facility
  • Southern Magnesium and Chemicals Ltd Q4FY22 loss at Rs. 21.03 lakhs

Industry News

  • Unocoin Undergoes Complete Rebranding in Bid to Drive Demographic Expansion

Latest Post

  • Akar Auto Industries Ltd Q1FY23 net profit drops QoQ to Rs. 1.22 crore
  • Chemtech Industrial Valves Ltd Q1FY23 PAT up at Rs. 33.47 lakhs
  • Mohit Paper Mills Ltd posts net profit of Rs. 85.45 lakhs in Q1FY23
  • Mindteck India Ltd reports Rs. 5.12 crores consolidated PAT in Q1FY23
  • KJMC Financial Services Ltd consolidated Q1FY23 loss at Rs. 52.98 lakhs


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2021